Modalert (Modafinil) Tablets: Uses, Dosing, and Safety

Modalert is an oral tablet containing modafinil, a wakefulness-promoting medicine used to manage excessive sleepiness in adults with certain diagnosed sleep disorders. In the United States, modafinil is a prescription-only Schedule IV controlled substance. It can improve wakefulness, but it does not cure narcolepsy, correct an obstructed airway during sleep, or replace adequate sleep.

What Modalert Is

Modalert tablets contain modafinil as the sole active ingredient and are taken by mouth. We offer 100 mg and 200 mg tablets, with multiple package quantities ranging from 30 to 360 pills. The tablet should be swallowed as directed rather than treated as a chewable, dissolving, or extended-release dosage form.

Modafinil belongs to a group of medicines called wakefulness-promoting agents. It is related neither to a sleeping pill nor to treatment for ordinary fatigue. A clinician should first evaluate persistent sleepiness because inadequate sleep, medication effects, depression, thyroid disease, anemia, untreated sleep apnea, and other medical problems can produce similar symptoms.

Conditions Associated With Excessive Sleepiness

The established US uses of modafinil concern excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder. These conditions have different causes, so confirming the diagnosis matters before treatment begins.

• Narcolepsy: a chronic neurologic disorder that disrupts normal control of sleep and wakefulness. Modafinil can reduce excessive daytime sleepiness, but it does not reliably treat every symptom, such as cataplexy.
• Obstructive sleep apnea: repeated airway obstruction fragments sleep and may leave a person sleepy during the day. Modafinil may be considered for residual sleepiness, but it does not treat the obstruction and must not replace primary therapy such as positive airway pressure when that treatment is indicated.
• Shift work disorder: sleepiness and insomnia can occur when a recurring work schedule overlaps with the person's usual sleep period. Medicine may support wakefulness during work, but sleep scheduling and adequate opportunities for rest remain important.

Modafinil is not approved as a general study aid, weight-loss medicine, athletic performance enhancer, or substitute for sleep. Using it for those purposes can expose a person to interactions and serious adverse effects without addressing the reason for fatigue.

How Modafinil Works

Modafinil's exact mechanism is not fully understood. It binds to and inhibits the dopamine transporter, increasing extracellular dopamine in parts of the brain. Its wakefulness effects also involve downstream changes in other signaling systems and wake-promoting regions, including pathways associated with norepinephrine, histamine, glutamate, and gamma-aminobutyric acid.

This pharmacology differs from that of amphetamine, but the distinction does not make modafinil risk-free or non-stimulating. It can cause insomnia, anxiety, cardiovascular effects, misuse, and dependence. Its potential for misuse is one reason it is federally classified as a Schedule IV controlled substance.

What to Expect From Treatment

Clinical studies of approved modafinil products have shown improvements in objective and patient-reported measures of wakefulness in adults with the indicated sleep disorders. Improvement does not mean that sleepiness will disappear completely, and individual responses vary. A person may remain too sleepy to drive or perform hazardous work even when taking the medicine.

Treatment should be considered one part of a broader plan. Positive airway pressure remains central to treating obstructive sleep apnea when prescribed. People with shift work disorder still need a protected sleep period, and people with narcolepsy may require scheduled naps or additional treatment for symptoms not controlled by modafinil.

Strengths and General Dosage Principles

We offer Modalert tablets in 100 mg and 200 mg strengths. The following regimens describe established general dosing principles for modafinil in adults; they are educational examples, not a personalized prescription.

• Narcolepsy or obstructive sleep apnea: the usual recommended adult dose is 200 mg once daily in the morning.
• Shift work disorder: the usual recommended adult dose is 200 mg once daily, taken approximately one hour before the work shift begins.
• Severe liver impairment: the usual modafinil dose is generally reduced by half because exposure to the medicine can increase.
• Older adults: a lower dose and closer monitoring may be appropriate because elimination can slow with age.

Doses up to 400 mg per day have been tolerated in clinical studies of approved products, but they have not consistently provided additional benefit over 200 mg per day. A person should not increase the dose or take an extra tablet to compensate for persistent sleepiness without speaking with the prescriber.

Food does not substantially change total absorption, although it can delay the time to peak concentration. Taking modafinil late in the day may interfere with sleep because its effects can continue for many hours. Instructions for a missed dose should account for the time of day and the person's work or sleep schedule; taking it too late may be more disruptive than skipping it, so individualized advice should come from the prescriber or pharmacist.

Elimination and Half-Life

After an oral dose, modafinil generally reaches peak blood concentrations in about two to four hours. It is extensively metabolized, mainly in the liver, and its metabolites are eliminated largely in urine. The effective elimination half-life is approximately 15 hours in most adults, although liver function, age, interacting medicines, and individual metabolism can change this.

A half-life of about 15 hours helps explain why a morning dose can support wakefulness well into the day and why a dose taken too late can cause nighttime insomnia. It does not indicate exactly how long every person will feel an effect or how long the medicine may be detectable in a laboratory test.

Important Safety Information

Serious skin and allergic reactions

Rare but potentially life-threatening skin reactions have occurred with modafinil, including Stevens-Johnson syndrome and other severe reactions involving the skin or mucous membranes. There is no reliable way to predict whether a mild-looking rash will become serious. Stop taking the medicine and contact a clinician immediately if a rash develops unless a clinician clearly determines that it is unrelated. Call 911 for blistering or peeling skin, sores in the mouth or eyes, facial or throat swelling, trouble breathing, or other signs of a severe reaction.

Psychiatric symptoms

Modafinil can cause or worsen anxiety, agitation, depression, mania, hallucinations, aggression, or suicidal thoughts. Risk may be more concerning in someone with a history of psychosis, bipolar disorder, depression, or another psychiatric illness. New severe behavioral changes, hallucinations, mania, or thoughts of self-harm require urgent medical assessment.

Heart and blood pressure effects

Some people experience a faster heartbeat, palpitations, chest pain, or increased blood pressure. Prescribers may monitor heart rate and blood pressure, particularly when cardiovascular disease or hypertension is present. Special caution is appropriate in people who previously developed a syndrome involving mitral valve prolapse or left ventricular hypertrophy while using a central nervous system stimulant. Chest pain, fainting, severe shortness of breath, or a sustained irregular heartbeat warrants urgent care.

Pregnancy and breastfeeding

Human pregnancy data are limited, and animal studies have shown developmental toxicity. Modafinil should be used during pregnancy only when the potential benefit justifies the potential fetal risk. It is not known whether modafinil or its metabolites pass into human milk, so a breastfeeding patient should discuss potential risks, alternatives, and infant monitoring with a clinician.

Modafinil can reduce the effectiveness of steroidal hormonal contraceptives. A prescriber or pharmacist can recommend an alternative or additional contraceptive method during treatment and for one month after the last dose.

Children and adolescents

Modafinil is not approved for pediatric patients in the United States. Safety and effectiveness have not been established, and pediatric modafinil trials reported serious skin reactions and psychiatric adverse events. It should not be given to a child unless an appropriately qualified specialist has specifically directed its use.

Driving and hazardous work

Improved alertness does not guarantee normal judgment, coordination, or reaction time. People with excessive sleepiness may also underestimate how impaired they remain. Avoid driving, operating machinery, or doing other hazardous work until the condition is adequately controlled and it is clear how the medicine affects performance.

Prescription Status and Our Ordering Policy

Modafinil is available in the United States only by prescription and is a Schedule IV controlled substance under federal law.

That national regulatory classification is separate from our ordering process. Our current ordering policy does not require a prescription upload for us to accept a Modalert order at checkout. This checkout requirement does not change modafinil's prescription-only legal classification or replace appropriate evaluation and prescribing by a qualified clinician.

If you have questions about our ordering process, our support team is available 24/7 by email or online chat. A pharmacist is also available through our support service for medicine-related questions.

Who Should Not Take Modafinil

Modafinil is contraindicated in anyone with known hypersensitivity to modafinil, armodafinil, or an ingredient in the tablet. A previous serious rash, angioedema, or other hypersensitivity reaction associated with modafinil or armodafinil is particularly important to disclose.

Other conditions are not always absolute contraindications, but they require careful assessment. These include uncontrolled high blood pressure, heart rhythm problems, significant cardiovascular disease, severe liver impairment, a history of psychosis or mania, depression, anxiety disorders, and previous substance misuse. A complete medication and health history helps the prescriber decide whether monitoring, a lower dose, or a different medicine is more appropriate.

Drug, Contraceptive, and Lifestyle Interactions

Modafinil can induce some liver enzymes and inhibit others, which may lower the effectiveness of certain medicines while increasing exposure to others. Hormonal contraceptives, some seizure medicines, anticoagulants, immunosuppressants, antidepressants, and other drugs can require special review. Share all prescription medicines, nonprescription products, vitamins, and supplements with the prescriber or pharmacist before treatment begins.

Combining modafinil with other stimulants or large amounts of caffeine may intensify insomnia, anxiety, tremor, palpitations, or increased blood pressure. The interaction between modafinil and alcohol has not been adequately characterized. Because alcohol can impair judgment and alertness, avoiding the combination is the cautious choice unless a clinician advises otherwise.

Side Effects and What to Do

Commonly reported adverse effects include headache, nausea, nervousness, anxiety, dizziness, indigestion, diarrhea, back pain, a runny nose, reduced appetite, and difficulty sleeping. Taking the medicine at the intended time may reduce sleep disruption, but persistent or troublesome effects should be discussed with a clinician rather than managed by changing the dose independently.

Stop taking modafinil and obtain prompt medical advice for a new rash, mouth sores, fever associated with skin symptoms, or signs of an allergic reaction. Seek emergency care for blistering or peeling skin, facial or throat swelling, difficulty breathing, severe chest pain, fainting, or a dangerous change in heart rhythm.

Urgent psychiatric warning signs include hallucinations, mania, severe agitation, aggression, profound depression, or thoughts of self-harm. In the United States, call 911 or go to the nearest emergency department when symptoms present an immediate danger.

Overdose and Accidental Ingestion

Taking more modafinil than directed can cause severe insomnia, restlessness, agitation, confusion, disorientation, nausea, tremor, elevated blood pressure, a fast or irregular heartbeat, chest pain, or hallucinations. Effects can vary, and the absence of early symptoms does not make an overdose safe.

For a suspected overdose or accidental ingestion in the United States, contact Poison Control immediately at 1-800-222-1222 or through poisonhelp.org. Call 911 for collapse, a seizure, trouble breathing, inability to wake, severe chest symptoms, or any other immediately life-threatening reaction. Do not induce vomiting unless a medical professional specifically instructs you to do so.

How to Store Modalert

Store the tablets at 68°F to 77°F in a tightly closed container, protected from moisture, excess heat, and light. Keep them out of reach of children and away from anyone for whom they were not prescribed. Do not use tablets after the labeled expiration date, and keep enough identifying information with the medicine to distinguish the strength and product.

Because modafinil is a controlled substance, it should be stored securely and never shared. Ask a pharmacist about an appropriate take-back or disposal option for tablets that are expired or no longer needed.

Potential Benefits and Trade-Offs

For an appropriately diagnosed adult, modafinil may improve wakefulness with convenient once-daily dosing. It may be considered when excessive sleepiness continues despite suitable management of the underlying disorder. Its pharmacology and adverse-effect profile differ from those of amphetamine-based stimulants, which can make it a useful option for some patients.

The trade-offs are substantial enough to require individualized review. Modafinil can cause serious skin, allergic, psychiatric, and cardiovascular reactions; it can reduce hormonal contraceptive effectiveness; and it interacts with several medicine groups. It also has misuse and dependence potential, remains a controlled substance, and cannot replace sleep or primary treatment for obstructive sleep apnea. Benefits should be assessed by improved function and safely maintained wakefulness, not simply by whether the medicine makes sleep more difficult.

Modafinil Products and Therapeutic Alternatives

Modalert and Provigil are brands of oral modafinil tablets. Products can differ in inactive ingredients and manufacturer, so confirm the prescribed strength and dosage form before changing between them.

A generic equivalent is a regulator-approved product judged equivalent to a reference medicine. A therapeutic alternative contains a different active ingredient and may work through a different mechanism. These are not the same kind of comparison.

• Armodafinil: the R-enantiomer of modafinil and another wakefulness-promoting medicine. Its exposure pattern and dosing are not identical to modafinil's.
• Solriamfetol: a dopamine and norepinephrine reuptake inhibitor used for excessive sleepiness associated with narcolepsy or obstructive sleep apnea.
• Pitolisant: a histamine H3 receptor antagonist/inverse agonist used for narcolepsy. Unlike modafinil, it is not federally scheduled as a controlled substance.
• Traditional stimulants: medicines such as methylphenidate may be considered in selected cases, but their dosing, contraindications, cardiovascular effects, and misuse risks differ.

No alternative is a direct drop-in replacement. The best choice depends on the diagnosis, other symptoms, cardiovascular and psychiatric history, pregnancy considerations, interacting medicines, previous response, and access to an appropriately regulated product.